TickerFactsScreenerDevelopers

ALNYLAM PHARMACEUTICALS, INC. (ALNY) — Net Income

Annual figures by fiscal year, from SEC filings.

2008: -$26.25M2009: -$47.59M2010: -$43.52M2011: -$57.65M2012: -$106.01M2013: -$89.22M2014: -$360.39M2015: -$290.07M2016: -$410.11M2017: -$490.87M2018: -$761.50M2019: -$886.12M2020: -$858.28M2021: -$852.82M2022: -$1.13B2023: -$440.24M2024: -$278.16M2025: $313.75M$313.75M
2008Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025$313.75M+212.8%
2024-$278.16M+36.8%
2023-$440.24M+61.1%
2022-$1.13B-32.6%
2021-$852.82M+0.6%
2020-$858.28M+3.1%
2019-$886.12M-16.4%
2018-$761.50M-55.1%
2017-$490.87M-19.7%
2016-$410.11M-41.4%
2015-$290.07M+19.5%
2014-$360.39M-303.9%
2013-$89.22M+15.8%
2012-$106.01M-83.9%
2011-$57.65M-32.5%
2010-$43.52M+8.6%
2009-$47.59M-81.3%
2008-$26.25M—